Dongshin to take over 6 products from Wyeth.

Published: 2005-09-07 06:59:00

Updated: 2005-09-07 06:59:00

Dongshin made a licence agreement with Wyeth Korea for the transfer of 6 brand drugs on Sept. 1 including Ozex, a quinolone antibiotic, Varidase, an anti-inflammatory enzyme, Minocin cap. a broad spectrum antibiotic, Ledercort tab. an oral steroid corticoid, Bisderm cream, a topical steroid and D...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK